Simultaneous expression of keratan sulphate epitope (a sulphated poly-N-acetyllactosamine) and blood group ABH antigens in papillary carcinomas of the human thyroid gland.
The monoclonal antibody 5-D-4 recognizes heavily sulphated forms of keratan sulphate epitope. It reacted strongly with the cell surfaces of most thyroid papillary carcinomas from all the individuals examined, independently of the blood group of the patients. Cells of follicular variants of papillary carcinomas were also labelled by 5-D-4. In contrast, no labelling with this antibody was observed in other types of thyroid neoplasms, or in normal tissues. The reactivity of 5-D-4 with papillary carcinomas was markedly reduced or abolished by prior digestion with endo-beta-galactosidase, keratanase II, or N-glycosidase F. Although keratanase digestion had no effect on 5-D-4 labelling, it revealed the binding sites of Griffonia simplicifolia agglutinin II (GSA-II), which recognizes terminal N-acetylglucosamine in a limited number of carcinoma cells from some individuals. Blood group ABH antigens, which are simultaneously expressed together with keratan sulphate epitope in cancer cells, were eliminated by digestion with endo-beta-galactosidase and N-glycosidase F, but were resistant to keratanase and keratanase II treatment. These results indicate that keratan sulphate oligosaccharides are cancer-associated and are probably oncofoetal antigens, as are the blood group antigens in human thyroid glands. The results suggests that poly-N-acetyllactosamine, which is ubiquitously and consistently produced in papillary carcinomas, is modified in two different ways: sulphation on the 6-position of at least some units of either galactose or N-acetylglucosamine or both, and decoration of non-reducing termini with the blood group antigens. Along with the endo-beta-galactosidase-GSA-II labelling procedure, labelling with 5-D-4 may be a useful diagnostic means for distinguishing papillary carcinoma from other types of thyroid neoplasms.
Department of Legal Medicine, Nara Medical University, Japan.
N
N
Ito
M
M
Yokota
C
C
Nagaike
Y
Y
Morimura
K
K
Hatake
O
O
Tanaka
T
T
Matsunaga
D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal; D001706:Biopsy; D002291:Carcinoma, Papillary / Q000378:metabolism*; D000939:Epitopes / Q000032:analysis*; D006026:Glycoside Hydrolases; D006801:Humans; D007632:Keratan Sulfate / Q000032:analysis*; D011134:Polysaccharides / Q000378:metabolism; D013964:Thyroid Neoplasms / Q000378:metabolism*; D001616:beta-Galactosidase / Q000378:metabolism
D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal; D000939:Epitopes; D011134:Polysaccharides; C037199:poly-N-acetyllactosamine; D007632:Keratan Sulfate; D006026:Glycoside Hydrolases; C026093:keratan-sulfate endo-1,4-beta-galactosidase; D001616:beta-Galactosidase